• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Commentators and Journalists Weigh In On Digital Health And Related Privacy, Safety, Social Media And Security Matters. Lots Of Interesting Perspectives - September 13, 2022.
-----This weekly blog is to explore the news around the larger issues around Digital Health, data security, data privacy, AI / ML. technology, social media and any related matters.I will also try to highlightADHA Propagandawhen I come upon it.Just so we keep count, the latest Notes from the ADHA Board were dated 6 December, 2018 and we have seen none since! It ’s pretty sad!Note: Appearance here is not to suggest I see any credibility or value in what follows. I will leave it to the reader to decide what is worthwhile and what is not! The point is to let people know what is being said / published that I have come upon, a...
Source: Australian Health Information Technology - September 13, 2022 Category: Information Technology Authors: Dr David G More MB PhD Source Type: blogs

The Macro View – Health, Economics, and Politics and the Big Picture. What I Am Watching Here And Abroad.
September 01, 2022 Edition-----This week it is all about weather and climate change with floods, heatwaves and droughts in Parkistan, Europe and China. In the US drought is causing all sorts of food supply issues and price rises.In the EU was a seeing all sorts of energy supply problems.In Australia we have a feast of investigations into ScoMo, RoboDebt and so on. Lots to browse!-----Major Issues.-----https://www.afr.com/policy/foreign-affairs/us-alliance-fear-that-dare-not-speak-its-name-20220818-p5bat8US alliance fear that dare not speak its nameUneasiness about divided, inward-looking America fulfilling its security gua...
Source: Australian Health Information Technology - September 1, 2022 Category: Information Technology Authors: Dr David G More MB PhD Source Type: blogs

A 100-Year-Old Martian In An Exoskeleton
The story of The Medical FuturistThe mission of a futuristThe most transformative technology: A.I.The mission of The Medical FuturistThe business modelCommunication of science to wide audiencesScience fiction and scienceData measurementData privacyAdvice to health policy-makersThe gap between the haves and have-nots Nightmare scenarios The future of the doctor-patient relationshipGenetics and gene editingMars and healthcare What do archaeologists and futurists have in common? Why was the Internet underestimated as a technology to transform society while A.I. is over-hyped? What’s the most transformative concept in hea...
Source: The Medical Futurist - February 12, 2019 Category: Information Technology Authors: nora Tags: Great Thinkers Source Type: blogs

A (Global) Cornucopia Of Clues To Optimize Medication Use
The most common patient care intervention, issuing a prescription, is fraught with continuing challenges for patients, their caregivers, and practitioners. Patients rely on medications across a continuum of care, with expectations for self-management; some experience unintended problems along the way. For older patients, such problems often result in emergency hospitalizations, many of which could be prevented. Historically, integration to support safe and appropriate medicine use across the U.S. health care ecosystem has been sporadic, including within our siloed Medicare Part D benefit. Other countries, however, are well...
Source: Health Affairs Blog - January 6, 2015 Category: Health Management Authors: N. Lee Rucker, Michael Holden, Parisa Aslani, and Rana Ahmed Tags: All Categories Global Health Health Care Costs Health Care Delivery Pharma Policy Public Health Source Type: blogs

NIH and Other Public Private Partnerships to Research Treatments for Multiple Diseases
Over the past few weeks, the National Institutes of Health (NIH) has made a number of important announcements regarding collaborations with industry as well as the funding of several new research initiatives. Below is a summary of these stories. NIH Partners With Eli Lilly and Others on Rare Diseases FierceBiotechResearch reported that NIH selected four (4) new preclinical drug development studies to uncover new therapies for rare diseases. The projects will be funded through the Therapeutics for Rare and Neglected Diseases (TRND) program under NIH's National Center for Advancing Translational Sciences, NCATS, which ...
Source: Policy and Medicine - October 4, 2013 Category: Health Medicine and Bioethics Commentators Authors: Thomas Sullivan Source Type: blogs